Review ArticleExtending the Boundaries of Cardiac Resynchronization Therapy: Efficacy in Atrial Fibrillation, New York Heart Association Class II, and Narrow QRS Heart Failure Patients
Section snippets
Methods
Studies were eligible for inclusion in this meta-analysis if they compared the benefits of CRT between patients with (1) narrow QRS and wide QRS, (2) AF and SR, or (3) NYHA Class II and NYHA Class III/IV symptoms. Studies that described the benefits of CRT in patients with narrow QRS, SR, or NYHA II in comparison to similar patients who did not receive CRT were not able to be meta-analyzed because of the paucity of such studies. To compare and pool study results, “narrow QRS” was defined in
Results
Our search for studies, conducted in accordance with the Quality of Reporting of Meta-analyses (QUOROM) statement, is summarized in Figure 1. We identified 227 potentially suitable articles. Of these, 17 met our inclusion criteria. Four of these studies were not included in the analysis, as they did not report end points, which were also reported in at least 2 other studies6, 7, 8 or did not provide all the required data for meta-analysis.9 The remaining 13 studies were analyzed.10, 11, 12, 13,
Discussion
The results of this study demonstrate that CRT may potentially have applications beyond the current standard indications of SR, NYHA Class III/IV symptoms, widened QRS, and LVEF <35%.
A similar improvement in NYHA class and LVEF was observed in patients with atrial fibrillation and those in sinus rhythm. In addition, this study demonstrated a similar benefit from CRT in patients with NYHA Class II compared with NYHA Class III/IV symptoms for the end points of left ventricular end-diastolic
References (30)
- et al.
Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses
Lancet
(1999) - et al.
Monitoring of physical activity and heart rate variability in patients with chronic heart failure using cardiac resynchronization devices
Am J Cardiol
(2005) - et al.
Long-term effectiveness of cardiac resynchronization therapy in patients with refractory heart failure and “narrow” QRS
J Am Coll Cardiol
(2003) - et al.
Cardiac resynchronization therapy in patients with a narrow QRS complex
J Am Coll Cardiol
(2006) - et al.
Comparison of usefulness of cardiac resynchronization therapy in patients with atrial fibrillation and heart failure versus patients with sinus rhythm and heart failure
Am J Cardiol
(2007) - et al.
Four-year efficacy of cardiac resynchronization therapy on exercise tolerance and disease progression: the importance of performing atrioventricular junction ablation in patients with atrial fibrillation
J Am Coll Cardiol
(2006) Initial experience with an implantable cardioverter-defibrillator incorporating cardiac resynchronization therapy
J Am Coll Cardiol
(2002)- et al.
Comparison of the effects of cardiac resynchronization therapy in patients with class II versus class III and IV heart failure (from the InSync/InSync ICD Italian Registry)
Am J Cardiol
(2007) - et al.
Comparative effects of permanent biventricular pacing for refractory heart failure in patients with stable sinus rhythm or chronic atrial fibrillation
Am J Cardiol
(2000) - et al.
Long-term benefits of biventricular pacing in congestive heart failure: results from the MUltisite STimulation in cardiomyopathy (MUSTIC) study
J Am Coll Cardiol
(2002)
Comparison of response to cardiac resynchronization therapy in patients with sinus rhythm versus chronic atrial fibrillation
Am J Cardiol
Benefits of cardiac resynchronization therapy for heart failure patients with narrow QRS complexes and coexisting systolic asynchrony by echocardiography
J Am Coll Cardiol
St John Sutton M, Ghio S, Daubert C. Randomized trial of cardiac resynchronization in mildly symptomatic heart failure patients and in asymptomatic patients with left ventricular dysfunction and previous heart failure symptoms
J Am Coll Cardiol
Ventricular contraction abnormalities in dilated cardiomyopathy: effect of biventricular pacing to correct interventricular dyssynchrony
J Am Coll Cardiol
Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay
N Engl J Med
Cited by (0)
Prof Henry Krum is on the executive committee of the EchoCRT trial, which is sponsored by Biotronik, Inc.